Senator McCaskill Continues to Fight Big Pharma

(Washington) Prescription drug prices continue to soar and Missouri’s senior United States senator continues fight for everyday Missourians.

This week, Claire McCaskill slammed the influence of pharmaceutical companies in Congress at a Senate Finance Committee hearing. 

Senator McCaskill says “Big Pharma” has cashed in, especially after the new tax bill went into effect.

In earnings calls and documents, 20 of the top 37 Fortune 500 health care companies, including pharmaceutical and health insurance companies, have detailed annual shareholder savings of $10 billion a year, adding up to an approximate $100 billion corporate windfall over ten years from last year’s tax bill, according to a recent Senate Finance Committee report.